Literature DB >> 25594118

Preliminary evidence of the association between monochlorinated bisphenol A exposure and type II diabetes mellitus: A pilot study.

Syam S Andra1, Harris Kalyvas, Xanthi D Andrianou, Pantelis Charisiadis, Costas A Christophi, Konstantinos C Makris.   

Abstract

Evidence for the association of bisphenol A (BPA) with type II diabetes mellitus (T2DM) has been inconsistent in human studies. In-vitro and animal studies indicate that chlorinated BPA derivatives aggravate BPA health effects via higher estrogenic activity and alteration of membrane-initiating signaling pathways. We evaluated the association between urinary monochlorinated BPA (mono-ClBPA) concentrations and the incidence of T2DM. In our cross-sectional study, we identified 20 adult participants (≥18 yr) who reported having T2DM (doctor-diagnosed) and 131 adults with normal health. First morning void urine samples were analyzed for total BPA and mono-ClBPA. Detection limits of the analytical method were 95 ng L(-1) for BPA and 32 ng L(-1) for mono-ClBPA. Multivariable logistic regression analyses and additive Bayesian network modeling were performed. After adjusting for age, gender, BMI, urinary total BPA and other confounders, the odds of having T2DM was 3.29 times higher (95% confidence interval, CI: 1.10, 11.4; P < 0.05) per unit increase in log-transformed and creatinine-adjusted urinary mono-ClBPA levels (n = 151); this relation did not hold for total BPA. The globally optimum Bayesian model corroborated the results of the logistic regression by expressing mono-ClBPA in the pathway of T2DM, and not for total BPA. An age-matched sensitivity analysis confirmed the increase in OR of T2DM by 3.04 times (95% CI: 1.10, 11.0; P < 0.05) per unit increase in log-transformed and creatinine-adjusted urinary mono-ClBPA concentration (n = 68). The urinary monochlorinated BPA derivative was significantly associated with T2DM, whereas the parent compound (total BPA) was not. Caution should be applied in interpreting these findings, as this is the first study to report this association and the sample size of participants with T2DM is small. Additional research with a larger sample size coupled with relevant toxicological studies is warranted.

Entities:  

Keywords:  Bisphenol A; exposure biomarkers; monochlorinated bisphenol A; trihalomethanes; type 2 diabetes

Mesh:

Substances:

Year:  2015        PMID: 25594118     DOI: 10.1080/10934529.2015.981111

Source DB:  PubMed          Journal:  J Environ Sci Health A Tox Hazard Subst Environ Eng        ISSN: 1093-4529            Impact factor:   2.269


  11 in total

1.  Hepatic metabolism of chlorinated derivatives of bisphenol A (ClxBPA) and interspecies differences between rats and humans.

Authors:  N Plattard; N Venisse; P Carato; A Dupuis; Sami Haddad
Journal:  Arch Toxicol       Date:  2022-01-24       Impact factor: 5.153

Review 2.  Protective effects of polyphenols against endocrine disrupting chemicals.

Authors:  Matthew P Madore; Junichi R Sakaki; Ock K Chun
Journal:  Food Sci Biotechnol       Date:  2022-07-12       Impact factor: 3.231

Review 3.  The association between bisphenol A exposure and type-2 diabetes: a world systematic review.

Authors:  Mohammad H Sowlat; Saeedeh Lotfi; Masud Yunesian; Reza Ahmadkhaniha; Noushin Rastkari
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-20       Impact factor: 4.223

Review 4.  Applications of artificial intelligence in drug development using real-world data.

Authors:  Zhaoyi Chen; Xiong Liu; William Hogan; Elizabeth Shenkman; Jiang Bian
Journal:  Drug Discov Today       Date:  2020-12-24       Impact factor: 7.851

5.  Association between cadmium exposure and diabetes mellitus risk: a prisma-compliant systematic review and meta-analysis.

Authors:  Ming Wu; Jukun Song; Chen Zhu; Yadong Wang; Xinhai Yin; Guanglei Huang; Ke Zhao; Jianguo Zhu; Zhuhui Duan; Lingkai Su
Journal:  Oncotarget       Date:  2017-10-20

6.  Evaluation of low doses BPA-induced perturbation of glycemia by toxicogenomics points to a primary role of pancreatic islets and to the mechanism of toxicity.

Authors:  E Carchia; I Porreca; P J Almeida; F D'Angelo; D Cuomo; M Ceccarelli; M De Felice; M Mallardo; C Ambrosino
Journal:  Cell Death Dis       Date:  2015-10-29       Impact factor: 8.469

7.  Bisphenol A exposure and type 2 diabetes mellitus risk: a meta-analysis.

Authors:  Semi Hwang; Jung-Eun Lim; Yoonjeong Choi; Sun Ha Jee
Journal:  BMC Endocr Disord       Date:  2018-11-06       Impact factor: 2.763

8.  Association between Heavy Metals, Bisphenol A, Volatile Organic Compounds and Phthalates and Metabolic Syndrome.

Authors:  Yun Hwa Shim; Jung Won Ock; Yoon-Ji Kim; Youngki Kim; Se Yeong Kim; Dongmug Kang
Journal:  Int J Environ Res Public Health       Date:  2019-02-25       Impact factor: 3.390

9.  Overexposure to Bisphenol A and Its Chlorinated Derivatives of Patients with End-Stage Renal Disease during Online Hemodiafiltration.

Authors:  Astrid Bacle; Antoine Dupuis; Mohamed Belmouaz; Marc Bauwens; Guillaume Cambien; Nicolas Venisse; Pascale Pierre-Eugene; Sophie Potin; Virginie Migeot; Sarah Ayraud-Thevenot
Journal:  Biomolecules       Date:  2019-08-22

Review 10.  Developmental Bisphenol A Exposure Modulates Immune-Related Diseases.

Authors:  Joella Xu; Guannan Huang; Tai L Guo
Journal:  Toxics       Date:  2016-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.